Journal of Hematology & Oncology (Mar 2025)
Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Zwi N. Berneman,
- Maxime De Laere,
- Paul Germonpré,
- Manon T. Huizing,
- Yannick Willemen,
- Eva Lion,
- Hans De Reu,
- Jolien Van den Bossche,
- Jan Van den Brande,
- Pol Specenier,
- Sevilay Altintas,
- Peter A. van Dam,
- Nathalie Cools,
- Griet Nijs,
- Barbara Stein,
- Kim Caluwaerts,
- Annemiek Snoeckx,
- Bart Op de Beeck,
- Kirsten Saevels,
- Lynn Rutsaert,
- Irma Vandenbosch,
- Gizem Oner,
- Martin Lammens,
- Pierre Van Damme,
- Sian Llewellyn-Lacey,
- David A. Price,
- Yoshihiro Oka,
- Yusuke Oji,
- Haruo Sugiyama,
- Marie M. Couttenye,
- Ann L. Van de Velde,
- Viggo F. Van Tendeloo,
- Marc Peeters,
- Sébastien Anguille,
- Evelien L. J. M. Smits
Affiliations
- Zwi N. Berneman
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Maxime De Laere
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Paul Germonpré
- Department of Pneumology, Maria Middelares General Hospital
- Manon T. Huizing
- Division of Oncology & Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital
- Yannick Willemen
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Eva Lion
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Hans De Reu
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Jolien Van den Bossche
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Jan Van den Brande
- Division of Oncology & Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital
- Pol Specenier
- Division of Oncology & Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital
- Sevilay Altintas
- Division of Oncology & Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital
- Peter A. van Dam
- Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp
- Nathalie Cools
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Griet Nijs
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Barbara Stein
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Kim Caluwaerts
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Annemiek Snoeckx
- Division of Radiology, Antwerp University Hospital
- Bart Op de Beeck
- Division of Radiology, Antwerp University Hospital
- Kirsten Saevels
- Division of Hematology & Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital
- Lynn Rutsaert
- Division of Hematology & Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital
- Irma Vandenbosch
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Gizem Oner
- Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp
- Martin Lammens
- Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), Faculty of Medicine and Health Sciences, University of Antwerp
- Pierre Van Damme
- Centre for the Evaluation of Vaccination (CEV), Vaccine and Infectious Disease Institute, Faculty of Medicine and Medical Sciences, University of Antwerp
- Sian Llewellyn-Lacey
- Division of Infection and Immunity, Cardiff University School of Medicine
- David A. Price
- Division of Infection and Immunity, Cardiff University School of Medicine
- Yoshihiro Oka
- Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine
- Yusuke Oji
- Department of Clinical Laboratory and Biomedical Sciences, Integrated Health Design Initiative (IHDi), Osaka University Graduate School of Medicine
- Haruo Sugiyama
- Department of Cancer Immunology, Osaka University Graduate School of Medicine
- Marie M. Couttenye
- Division of Nephrology, Antwerp University Hospital
- Ann L. Van de Velde
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Viggo F. Van Tendeloo
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Marc Peeters
- Division of Oncology & Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital
- Sébastien Anguille
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- Evelien L. J. M. Smits
- Center for Cell Therapy & Regenerative Medicine (CCRG), Antwerp University Hospital (UZA)
- DOI
- https://doi.org/10.1186/s13045-025-01683-5
- Journal volume & issue
-
Vol. 18,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
